Learn More
Medchemexpress LLC CDK12-IN-E9 10mg | 2020052-55-3 | 434.53 | C24H30N6O2 | 10 MG

Supplier: Medchemexpress LLC HY117203A10MG
CDK12-IN-E9 is a research-grade small-molecule inhibitor that selectively and covalently inhibits cyclin-dependent kinase 12 (CDK12) and non-covalently inhibits CDK9. It is supplied as a solid for use in cellular and biochemical studies of transcriptional regulation and DNA damage response.
- Potent covalent CDK12 inhibition (IC50 23.9 nM).
- Non-covalent CDK9 activity (IC50 932 nM).
- High reported purity (~99.7%).
- Molecular weight 434.53 g/mol; formula C24H30N6O2.
- Soluble in DMSO (125 mg/mL with ultrasonic).
- Available in small research pack sizes suitable for early-stage experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.